Search filters

List of works by Jeanne Lusher

A Community-Based Partnership to Promote Information Infrastructure for Bleeding Disorders

scientific article published on December 1, 2011

A longer acting rFVIII, safe and effective

scientific article published in January 2014

A prophylactic transfusion program for children with sickle cell anemia complicated by CNS infarction

scientific article published on January 1, 1976

A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group

scientific article published in November 1998

Absence of inhibitory cells from patients with aplastic anemia or transient erythroblastopenia of childhood on the in vitro growth of erythroid colonies

scientific article published on 01 February 1980

Accurate prenatal diagnosis with novel polymerase chain reaction primers in a family with sporadic hemophilia A.

scientific article published in September 1989

Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection

scientific article published on 01 April 2007

Acute hemarthroses: the benefits of early versus late treatment with recombinant activated factor VII.

scientific article published in April 2000

Acute idiopathic thrombocytopenic purpura--management in childhood

scientific article published on 15 February 1997

Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk

scientific article published in March 1999

Anti-s hemolytic disease: a case report

scientific article published on 01 November 1966

Antibody nature of an AHG (factor 8) inhibitor

scientific article published in March 1968

Automated dithionite test for rapid, inexpensive detection of hemoglobin S and non-S sickling hemoglobinopathies

scientific article published on 01 October 1971

Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII

scientific article published on 01 November 1983

B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover study

scientific article

Bone changes in sickle cell disease

scientific article

Characterization of autoantibodies against the platelet glycoprotein antigens IIb/IIIa in childhood idiopathic thrombocytopenia purpura

scientific article

Childhood Idiopathic Thrombocytopenic Purpura

scientific article published on March 1, 1977

Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States

scientific article published on 09 February 2016

Clinical evaluation of moroctocog alfa (AF-CC), a new generation of B-domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full-length recombinant fa

scientific article

Clinical experience with recombinant factor VIIa

scientific article published on March 1, 1998

Clinical guidelines for treating von Willebrand disease patients who are not candidates for DDAVP--a survey of European physicians

scientific article published in January 1998

Clinical trials of the recombinant factor VIII product, Kogenate

scientific article published on October 1, 1992

Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor

scientific article

Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTH

scientific article published on 01 September 1995

Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System

scientific article

Congenital Disorders Affecting Platelets

scientific article published on January 1, 1977

Congenital Hemorrhagic Disorders: New Insights into the Pathophysiology and Treatment of Hemophilia

scientific article published on January 1, 2000

Congenital thrombocytopenias

scientific article published on September 1, 1995

Considerations for current and future management of haemophilia and its complications

scientific article published on January 1995

Current practices regarding newborn intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hem

scientific article published in November 1999

DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease

scientific article published in February 1983

DDAVP: does the drug have a direct effect on the vessel wall?

scientific article published on 01 July 1983

Decreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopenia

scientific article

Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis

scientific article published in March 2001

Desmopressin and thrombosis

scientific article published on 01 September 1989

Development and introduction of recombinant factor VIII – a clinician’s experience

scientific article published on April 19, 2012

Development of anaphylactic shock in haemophilia B patients with inhibitors.

scientific article published in March 1998

Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions

scientific article published on July 1, 1984

Dithionite tube test--a rapid, inexpensive technique for the detection of hemoglobin S and non-S sickling hemoglobin

scientific article published on 01 October 1971

Early treatment with recombinant factor VIIa results in greater efficacy with less product.

scientific article published in January 1998

Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Study Group

scientific article published in August 1992

Efficacy and safety of monoclonal antibody purified factor IX concentrate in haemophilia B patients undergoing surgical procedures

scientific article

Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial

scientific article published in August 1980

Emergency department visits in children with hemophilia

scientific article published on November 28, 2012

Erythropoiesis in Sickle Cell Anaemia during Acute Infection and Crisis

scientific article published on April 4, 1979

Ethanol lock therapy for the treatment of catheter-related infections in haemophilia patients

scientific article published on 29 July 2009

Evaluation of Oral Urea in the Management of Sickle Cell Anemia

scientific article published on 01 January 1972

Evolution of recombinant factor VIII safety: KOGENATE and Kogenate FS/Bayer

scientific article

Factor IX inhibitors and anaphylaxis in haemophilia B.

scientific article

Factor IX inhibitors and anaphylaxis in hemophilia B

scientific article published on 01 July 1997

Factor IX inhibitors and anaphylaxis in hemophilia B.

scientific article

Factor VIII concentrates: matching what you see with what you get

scientific article published on 01 August 1985

Factor VIII inhibitor assay using plasma F VIII versus recombinant F VIII--a comparative study

scientific article published in October 1994

Factor VIII inhibitors. Etiology, characterization, natural history, and management

scientific article published on January 1987

Familial warfarin resistance in a black child

scientific article published in January 1986

Festschrift in homor of Wolf W. Zuelzer, M.D

scientific article published on January 1, 1976

Fibrinolytic parameters in children with noncatheter thrombosis: a pilot study

scientific article published on 01 June 2010

First and second generation recombinant factor VIII concentrates in previously untreated patients: recovery, safety, efficacy, and inhibitor development

scientific article

Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII.

scientific article published in August 1993

Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical investigation

scientific article published on 01 March 2005

Gene therapy for hemophilia A and B: patient selection and follow-up, requirements for a cure.

scientific article

HIV and hemophilia

scientific article published in March 2007

Hematological parameters and marrow in vitro colony forming cells in acute lymphoblastic leukemia after cessation of treatment

scientific article published on 01 February 1980

Hematology

scientific article published on 01 June 1996

Hemophilia

scientific article published on 01 March 1991

Hemophilia A in chromosomal female subjects

scientific article published in February 1969

Hemophilia A.

scientific article

Hemophilia treatment. Factor VIII inhibitors with recombinant products: prospective clinical trials.

scientific article

Hemophilia: continued challenges but reason for optimism on many fronts

scientific article published in October 1993

Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study

scientific article published in October 2006

High-titer inhibitor development in hemophilia A: lack of product specificity

scientific article published in February 2004

Highlights from the XXV International Congress of the World Federation of Hemophilia. May 19-24, 2002, Seville, Spain

scientific article published on 18 June 2002

Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.

scientific article

How do you treat bleeding disorders with desmopressin?

scientific article published on March 2007

Human antibodies to recombinant factor VII in hemophiliacs

scientific article published in August 1994

Human recombinant DNA-derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5-year study of home therapy. The KOGENATE Study Group

scientific article published in January 1999

Human recombinant DNA-derived antihemophilic factor in the treatment of previously untreated patients with hemophilia A: final report on a hallmark clinical investigation

scientific article published in April 2004

IMFRA (intermittent intrathecal methotrexate and fractional radiation) plus chemotherapy in childhood leukemia

scientific article published on 01 January 1976

Idiopathic thrombocytopenic purpura in childhood

scientific article published on 01 June 1966

Idiopathic thrombocytopenic purpura in children. The case for management without corticosteroids

scientific article

Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group.

scientific article published in April 1994

Immune tolerance induction in 31 children with haemophilia A: is ITI less successful in African Americans?

scientific article published on December 1, 2010

Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors

scientific article published in May 2000

Immunoglobulins in idiopathic thrombocytopenic purpura in childhood

scientific article published on January 1, 1976

In vivo recovery with products of very high purity--assay discrepancies

scientific article published in July 1998

Increase in Leu 2+ Leu 7+ lymphocytes in HIV 1-seropositive patients with hemophilia repeatedly treated with clotting factor concentrates

scientific article

Inhibition of CD40 ligand (CD154) in the treatment of factor VIII inhibitors.

scientific article published in October 2000

Inhibitor antibodies to factor VIII and factor IX: management

scientific article

Inhibitor development in prospective clinical trials with recombinant factor VIII preparations in previously untreated patients

scientific article

Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006).

scientific article

Inhibitors in young boys with haemophilia

scientific article published on 01 September 2000

Initial clinical experience with a new pasteurized monoclonal antibody purified factor VIIIC.

scientific article published in April 1990

Intracranial and extracranial hemorrhages in newborns with hemophilia: a review of the literature

scientific article

Intravenous gamma globulin treatment for chronic idiopathic thrombocytopenic purpura in children

scientific article

Intravenous gammaglobulin (Gaminume) for treatment of chronic idiopathic thrombocytopenic purpura (ITP): a two-year follow-up

scientific article

Is the incidence and prevalence of inhibitors greater with recombinant products? No.

scientific article

Lack of inhibitor to monoclonal-antibody purified factor VIII concentrate

scientific article

Low CD4+ counts in a study of transfusion safety. The Transfusion Safety Study Group.

scientific article published in February 1993

Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group

scientific article

Macroglobulinemia in a child with acute leukemia

scientific article published on 01 February 1974

Management of patients with factor VIII inhibitors

scientific article

Milestones in hemophilia and concepts in future clinical trial design

scientific article

Modern treatment of haemophilia

scientific article published on January 1995

Nephrotic syndrome as a complication of immune tolerance in hemophilia B.

scientific article

Neurological complications of sickle cell anemia

scientific article published on 01 January 1982

New leukemia in the course of therapy of acute lymphoblastic leukemia

scientific article published on January 1, 1978

No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation

scientific article published on March 21, 2013

North American study of factor VIII concentrate potency

scientific article published in January 1984

On-demand treatment of bleeds in haemophilia patients with inhibitors: strategies for securing and maintaining predictable efficacy with recombinant activated factor VII.

scientific article published on 19 July 2011

Open heart surgery in a hemophiliac patient. Hematologic management

scientific article published in May 1974

Oral urea and the prophylactic treatment of sickle cell disease—a preliminary report

scientific article published on 01 June 1971

Panel discussion on the treatment of patients with factor VIII inhibitors.

scientific article published in January 1984

Passive antibody to hepatitis A virus in US haemophiliacs

scientific article published in February 1993

Pediatric reference values for molecular markers in hemostasis

scientific article published on 01 January 2007

Perinatal management of newborns with haemophilia

scientific article

Periodic Transfusions for Sickle Cell Anemia and CNS Infarction

scientific article published on 01 December 1979

Perspectives on the use of factor IX complex concentrates in the treatment of bleeding in persons with acquired factor VIII inhibition

scientific article published on November 4, 1991

Pharmacokinetics and pharmacodynamics of recombinant factor VIIa

scientific article published in June 1994

Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis. Cooperative Study Groups

scientific article published on 01 September 1996

Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion

scientific article published on 22 May 2003

Phenotypes of Allo- and Autoimmune Antibody Responses to FVIII Characterized by Surface Plasmon Resonance

scientific article published on May 8, 2013

Phenotypic change of acute monocytic leukemia to acute lymphoblastic leukemia on therapy

scientific article published on 01 January 1983

Plasma Homocysteine Levels, Methylene Tetrahydrofolate Reductase Polymorphisms, and the Risk of Thromboembolism in Children

scientific article published on July 1, 2011

Platelet-vessel-wall interactions: experiences with von Willebrand platelets

scientific article published on 01 January 1981

Prediction and management of adverse events associated with the use of factor IX complex concentrates

scientific article

Preoperative exchange transfusion in sickle cell anemia

scientific article published on 01 June 1981

Prophylactic therapy with Fibrogammin P is associated with a decreased incidence of bleeding episodes: a retrospective study

scientific article published on 15 December 2009

Prophylaxis in children with hemophilia: is it the optimal treatment?

scientific article published on 01 July 1997

Prothrombin complex concentrates in hemophiliacs with inhibitors--a multicenter therapeutic trial

scientific article published on 01 January 1980

Protocols, dosages and clinical aspects of immune tolerance

scientific article published on 01 January 1996

Pulmonary embolism-experience at a single children's hospital

scientific article published on 31 July 2006

Recent evolution of clotting factor concentrates for hemophilia A and B. Transfusion Practices Committee

scientific article

Recombinant activated factor VII for treatment of intramuscular haemorrhages: a comparison of early versus late treatment

scientific article published in March 1998

Recombinant clotting factor concentrates

scientific article published on June 1996

Recombinant clotting factors: a review of current clinical status

scientific article published on April 2000

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group

scientific article published in February 1993

Recombinant factor VIIa (NovoSeven) in the treatment of internal bleeding in patients with factor VIII and IX inhibitors

scientific article

Recombinant factor VIIa: a viewpoint by Jeanne M. Lusher

scientific article published on 01 July 1999

Response to 1-deamino-8-D-arginine vasopressin in von Willebrand disease

scientific article published on September 1994

Retrovir therapy in hemophilic children with symptomatic human immunodeficiency virus infection: efficacy and toxicity

scientific article (publication date: 1990)

Risk of human immunodeficiency virus type 1 infection among sexual and nonsexual household contacts of persons with congenital clotting disorders

scientific article published on August 1, 1991

Safety and efficacy of monoclonal antibody purified factor IX concentrate in previously untreated patients with hemophilia B.

scientific article published in January 1996

Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with haemophilia

scientific article published on March 2000

Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): results of a phase I study

scientific article published in August 1993

Screening and diagnosis of coagulation disorders

scientific article

Severe factor VIII and factor IX deficiency in females

scientific article published on October 1, 1978

Sickle cell crisis terminated by intravenous urea in sugar solutions—a preliminary report

scientific article published on 01 June 1971

Sickledex test for hemoglobin S. A critique

scientific article published on 01 December 1971

Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project

scientific article

Standardization of thromboelastography: a report from the TEG-ROTEM working group

scientific article published on 15 February 2011

Standardization of thromboelastography: values and challenges

scientific article published on October 26, 2010

Strategies to promote hemostasis in patients with F VIII inhibitors

scientific article published on January 1990

Summary of clinical experience with recombinant factor VIII products--Kogenate

scientific article published on 01 January 1994

Systemic causes of excessive uterine bleeding.

scientific article

The Detection of Sickle Cell Hemoglobin in Large Human Populations by an Automated Technique

scientific article published on 01 July 1972

The May-Hegglin anomaly: platelet function, ultrastructure and chromosome studies

scientific article published on 01 December 1968

The National Hemophilia Foundation provides a model of a national blood monitoring system

scientific article published in January 1996

The effect of 5-hydroxytryptamine and epinephrine on newborn platelets

scientific article published on July 1978

The incidence of development of irregular red cell antibodies in patients with sickle cell anemia

scientific article

The overall effectiveness of prophylaxis in severe haemophilia

scientific article published on May 1, 2003

The problem of therapeutic equivalence with paired qualitative data: an example from a clinical trial using haemophiliacs with an inhibitor to factor VIII.

scientific article

The role of prothrombin complex concentrates in the treatment of hemophiliacs with factor VIII inhibitors

scientific article published in January 1984

The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A.

scientific article published in January 2003

The safety and efficacy of B-domain deleted recombinant factor VIII concentrates in patients with severe haemophilia A: an update

scientific article

The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B.

scientific article

The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience

scientific article

The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapy

scientific article published on June 1989

Therapeutic and prophylactic ethanol lock therapy in patients with bleeding disorders

scientific article published on August 1, 2013

Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status

scientific article published in September 1993

Thromboelastography identifies children with rare bleeding disorders and predicts bleeding phenotype

scientific article published on January 2015

Thromboelastography in children with coagulation factor deficiencies

scientific article

Thrombogenicity associated with factor IX complex concentrates

scientific article published on July 1, 1991

Tissue plasminogen activator induced fibrinolysis: standardization of method using thromboelastography

scientific article published on 01 June 2010

Transfusion therapy in congenital coagulopathies

scientific article published on December 1994

Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIII concentrate.

scientific article

Transmission of human immunodeficiency virus type 1 by dry-heated clotting factor concentrates. Transfusion Safety Study Group

scientific article published in January 1990

Types of bleeding seen during the first 30 months of life in children with severe haemophilia A and B.

scientific article

Unresolved issues in diagnosis and management of inherited bleeding disorders in the perinatal period: a White Paper of the Perinatal Task Force of the Medical and Scientific Advisory Council of the National Hemophilia Foundation, USA.

scientific article

Use of central venous catheters in children with haemophilia: one haemophilia treatment centre experience

scientific article

Use of intravenous gamma globulin in children and adolescents with idiopathic thrombocytopenic purpura and other immune thrombocytopenias

scientific article

Use of prothrombin complex concentrates in management of bleeding in hemophiliacs with inhibitors--benefits and limitations.

scientific article published in April 1994

VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population

scientific article published on December 23, 2011

Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study Group

scientific article published on January 25, 1992

Viral safety and clotting factor concentrates

scientific article published on 01 October 1994

Viral safety and inhibitor development associated with factor VIIIC ultra-purified from plasma in hemophiliacs previously unexposed to factor VIIIC concentrates. The Monoclate Study Group

scientific article published on April 1990

Viral safety and inhibitor development associated with monoclonal antibody-purified F VIII C.

scientific article